The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of baseline PSMA PET in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) starting first-line (1L) androgen receptor signaling inhibitor (ARSI) therapy.
 
Ivan de Kouchkovsky
Consulting or Advisory Role - Janssen
 
Moein Moradpour
No Relationships to Disclose
 
Li Zhang
Consulting or Advisory Role - Samay Inc.; Smith-Kettlewell Eye Research Institute
 
Abuzar Moradi Tuchayi
No Relationships to Disclose
 
Xiaolin Zhu
Employment - Exelixis (I)
 
Roxanna Juarez
No Relationships to Disclose
 
Daniel Kwon
No Relationships to Disclose
 
Vadim Koshkin
Consulting or Advisory Role - Bicycle Therapeutics; Clovis Oncology; Gerson Lehrman Group; Guidepoint Global; Janssen; Loxo; MSD; Pfizer/EMD Serono; Seattle Genetics/Astellas
Research Funding - Clovis Oncology (Inst); Curium Pharma (Inst); Endocyte (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Pfizer (Inst); Seagen (Inst); Taiho Oncology (Inst)
Travel, Accommodations, Expenses - Astellas Pharma
 
Jonathan Chou
Consulting or Advisory Role - Exai Bio
Research Funding - Amgen (Inst)
 
Terence Friedlander
Honoraria - Abbvie; Astellas Pharma; EMD Serono; Merck
Consulting or Advisory Role - AADi; Astellas Pharma; Atkis; Bicycle Therapeutics; Bristol-Myers Squibb/Medarex; EMD Serono; Gilead Sciences; Janssen; Merck; Seagen
Research Funding - Bicycle Therapeutics; Bristol-Myers Squibb (Inst); Neon Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bicycle Therapeutics; Merck
 
Eric Small
Stock and Other Ownership Interests - Fortis; Teon Therapeutics
 
Rahul Aggarwal
Consulting or Advisory Role - Alessa Therapeutics; Amgen; AstraZeneca; Bayer; BioXcel Therapeutics; Boxer Capital; Curio Science; EcoR1 Capital; Exelixis; Flare Therapeutics; Guidepoint Inc; Harpoon therapeutics; Janssen; Merck; MJH Life Sciences; Novartis; PCCTC; Pfizer; Research to Practice; Slingshot Insights; Tersera; Washington Research Foundation
Research Funding - Amgen (Inst); AstraZeneca (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Xynomic Pharma (Inst); Zenith Epigenetics (Inst)
Expert Testimony - University of Utah Health
Travel, Accommodations, Expenses - DAVA Oncology
 
Thomas Hope
Stock and Other Ownership Interests - Curium Pharma; RayzeBio
Honoraria - GE Healthcare
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Curium Pharma; Ipsen; ITM Isotope Technologies Munich; Lantheus Medical Imaging
Research Funding - Advanced Accelerator Applications (Inst); Clovis Oncology (Inst); GE Healthcare (Inst); Janssen Oncology (Inst); Lantheus Medical Imaging (Inst); Novartis (Inst); Philips Healthcare (Inst); Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - GE Healthcare